CD8A and neoplasm: At the end of study (> day 28 post-initiation of bintrafusp alfa treatment), there was a trend in the increase in CD4+ and a significant increase in CD8+ T-cell infiltration per milligram tumor when comparing bintrafusp alfa to control treated animals (Figures 2E,F).